OVERVIEW

Cambridge Healthtech Institute (CHI)'s 4th Annual Advances in Prenatal Molecular Diagnostics and 2nd Annual Reproductive Genetic Diagnostics is organized by Cambridge Healthtech Institute (CHI) and would be held during Nov 29 - Dec 02, 2016 at Boston Marriott Cambridge, Cambridge, Massachusetts, United States Of America.

The target audience for this medical event basically for Physicians, Reproductive Endocrinologists, Embryologists, Cytogeneticists, Fertility Specialists, Maternal / Fetal Medicine, OB - GYN Physicians, Genetic Counselors, Andrologists.

The growing acceptance and availability of cell-free DNA-based screening from maternal blood is having a dramatic impact on prenatal testing. One result has been the steady decline in the number of women choosing invasive testing, with growing shift away from karyotyping in favor of arrays, or in some cases sequencing, for analysis of these samples. The range of approaches being employed for cell-free DNA testing continues to grow, including the release of kits for in-house analysis and so-called second generation assays that provide much improved detection of sub-chromosomal anomalies. There has been a push to expand NIPT use beyond higher-risk pregnancies, as well as extending the range of genetic conditions reported from the tests, but such changes come at a price.

Research into testing based on isolation of fetal cells from maternal blood has been underway for decades, and the discussion has been couched in terms of “if this approach can be commercialized”. At this meeting last year, for the first time, the conversation shifted to“when this approach is commercialized” as numerous groups reported substantial progress in achieving reliable isolation that would make this possible. Updated comparisons and examination of these issues, and the implementation of these different approaches, will again make for lively discussion and insight into where this field is headed and ways for researchers, test providers, clinicians and clinics to take these developments into consideration.

This conference examines the latest in preimplantation diagnostic and screening technologies, including their applications in assessing mtDNA load; determining aneuploidy through single-gene disorders; and assessing mosaicism. The meeting will also examine the potential for non-invasive PGD by blastocentesis, being developed in response to the potential effect biopsy and vitrification may have on the development of the embryo. There will be discussion on PGD for donor eggs, such as how much or how often testing should be done. The meeting will also cover advances in CRISPR, including current research and capabilities, as well as how this technology may or may not be used in the future. New this year, special attention will be paid to molecular diagnostics for finding infertility biomarkers in sperm and the uterus.

KEY DATES

Event Start Date
29 Nov, 2016
Event Start Date
Event End Date
02 Dec, 2016
Event End Date

SPECIALITIES

Obstetrics and GynecologyNeonatal and Perinatology

SUGGESTED HOTELS

CONFERENCE VENUE

Boston Marriott Cambridge
50 Broadway
Explore more options
Hotels
Flights
Rides

RELATED CONFERENCES & LIVE WEBINARS

WOMEN’S EMERGENCY MEDICINE: Pearls and Pitfalls of ED OB/GYN
Feb 19 - 23, 2024 | Key West, Florida,...
Emergency Medicine
20 AMA PRA Category 1 Credit™
More actions
US$1,079